117 related articles for article (PubMed ID: 14758731)
21. CD44 isoforms in metastatic cancer.
Ponta H; Sleeman J; Dall P; Moll J; Sherman L; Herrlich P
Invasion Metastasis; 1994-1995; 14(1-6):82-6. PubMed ID: 7544777
[TBL] [Abstract][Full Text] [Related]
22. The role of CD44v3 expression in female breast carcinomas.
Ryś J; Kruczak A; Lackowska B; Jaszcz-Gruchała A; Brandys A; Stelmach A; Reinfuss M
Pol J Pathol; 2003; 54(4):243-7. PubMed ID: 14998292
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
[TBL] [Abstract][Full Text] [Related]
24. Hyaluronate and its receptors in bone marrow.
Schade UM; Nehmann N; Horny HP; Prehm P; Delpech B; Krüger WH; Zander AR; Schumacher U
Acta Histochem; 2006; 108(2):141-7. PubMed ID: 16713618
[TBL] [Abstract][Full Text] [Related]
25. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M
Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810
[TBL] [Abstract][Full Text] [Related]
26. Changes in CD44 isoform expression during inflammatory skin disease.
Harris AJ; Dean D; Burge S; Wojnarowska F
Clin Exp Dermatol; 1997 May; 22(3):128-33. PubMed ID: 9425692
[TBL] [Abstract][Full Text] [Related]
27. Understanding the dual nature of CD44 in breast cancer progression.
Louderbough JM; Schroeder JA
Mol Cancer Res; 2011 Dec; 9(12):1573-86. PubMed ID: 21970856
[TBL] [Abstract][Full Text] [Related]
28. Upregulation and dephosphorylation of cofilin: modulation by CD44 variant isoform in human colon cancer cells.
Subramaniam V; Vincent IR; Jothy S
Exp Mol Pathol; 2005 Dec; 79(3):187-93. PubMed ID: 16229833
[TBL] [Abstract][Full Text] [Related]
29. CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity.
Hanley WD; Burdick MM; Konstantopoulos K; Sackstein R
Cancer Res; 2005 Jul; 65(13):5812-7. PubMed ID: 15994957
[TBL] [Abstract][Full Text] [Related]
30. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix.
Zhu H; Mitsuhashi N; Klein A; Barsky LW; Weinberg K; Barr ML; Demetriou A; Wu GD
Stem Cells; 2006 Apr; 24(4):928-35. PubMed ID: 16306150
[TBL] [Abstract][Full Text] [Related]
31. Soluble CD44 secretion contributes to the acquisition of aggressive tumor phenotype in human colon cancer cells.
Subramaniam V; Gardner H; Jothy S
Exp Mol Pathol; 2007 Dec; 83(3):341-6. PubMed ID: 17945213
[TBL] [Abstract][Full Text] [Related]
32. Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer.
Pries R; Witrkopf N; Trenkle T; Nitsch SM; Wollenberg B
In Vivo; 2008; 22(1):89-92. PubMed ID: 18396788
[TBL] [Abstract][Full Text] [Related]
33. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
[TBL] [Abstract][Full Text] [Related]
34. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY
Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338
[TBL] [Abstract][Full Text] [Related]
35. Osteopontin increases CD44 expression and cell adhesion in RAW 264.7 murine leukemia cells.
Marroquin CE; Downey L; Guo H; Kuo PC
Immunol Lett; 2004 Aug; 95(1):109-12. PubMed ID: 15325806
[TBL] [Abstract][Full Text] [Related]
36. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
[TBL] [Abstract][Full Text] [Related]
37. CD44 promotes resistance to apoptosis in human colon cancer cells.
Lakshman M; Subramaniam V; Rubenthiran U; Jothy S
Exp Mol Pathol; 2004 Aug; 77(1):18-25. PubMed ID: 15215046
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of CD44+/CD24-/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis.
Abraham BK; Fritz P; McClellan M; Hauptvogel P; Athelogou M; Brauch H
Clin Cancer Res; 2005 Feb; 11(3):1154-9. PubMed ID: 15709183
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms of metastasis.
Weber GF
Cancer Lett; 2008 Nov; 270(2):181-90. PubMed ID: 18522865
[TBL] [Abstract][Full Text] [Related]
40. Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?
Maxwell CA; McCarthy J; Turley E
J Cell Sci; 2008 Apr; 121(Pt 7):925-32. PubMed ID: 18354082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
